AbstractThis is a grant report on a study preceptorship undertaken in intensive care units at the Johns Hopkins Hospital (Baltimore); University of Chicago Medical Center; University of Chicago Medicine Comer Children's Hospital; RUSH University Medical Center (Chicago); Indiana University Health University and Methodist Hospitals (Indianapolis); St Vincent's Hospital (Indianapolis); and Eskenazi Health (Indianapolis). Key learning points from US critical care pharmacy practice models, Residency Programs, Specialist Board Certification and clinical information systems are highlighted. Comparisons between US and Australian practices are discussed. Hospira® and the Society of Hospital Pharmacists of Australia are acknowledged for funding this study preceptorship.